- RSV vaccine access expanded to some people in their 50s, according to CDC website AP News
- US CDC accepts ousted vaccine panel’s recommendations for RSV, meningococcal shots Reuters
- Kennedy Expands RSV Vaccine Recommendations. Moderna, Pfizer Shares Are Up. Barron’s
- ACIP Recommends Use of Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season Merck.com
- Robert F. Kennedy Jr. Just Did The Unexpected. He Helped Moderna. Investor’s Business Daily
